4th Annual Bradley Z. Naifeh Amyloidosis Conference - Medical Professional Conference - May 9, 2026 - FREE (NO CE CREDIT)

May 9, 2026

 

THIS REGISTRATION OPTION IS AVAILABLE ONLY FOR PRIVATE PHYSICIANS LOCATED WITHIN THE GREATER HOUSTON AREA.

CE CREDIT IS NOT AVAILABLE FOR THE FREE SESSION. PRIVATE PHYSICIANS WISHING TO RECEIVE CE CREDIT MUST REGISTER FOR AND PAY THE FAIR MARKET VALUE RATE FOR THE CE CREDIT OFFERING OF THIS ACTIVITY.  

 

Virtual attendance option only

Houston Methodist J.C. Walter Educational Series

Amyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.

Target Audience

Cardiologists, hematologists, neurologists, nephrologists, pulmonologists, hepatologists, nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities.

Learning Objectives

Upon completion of this course, the participant should be able to:

  • Identify and Diagnose Amyloidosis Early & Effectively
  • Apply Best Practices to Treat Amyloidosis
  • Utilize Appropriate Resources Available to Providers and Patients alike (non-profit institutions)
  • Describe the full influence of Amyloidosis: how it affects multiple specialties and all parts of the body, and how it becomes a fatal disease
  • List the multiple types of Amyloidosis

 

Course summary
Available credit: 
  • 3.25 Attendance
Course opens: 
02/24/2026
Course expires: 
06/09/2026
Event starts: 
05/09/2026 - 8:00am CDT
Event ends: 
05/09/2026 - 3:45pm CDT
Add to calendar: 
H O U S T O N    M E T H O D I S T    J . C .     W A L T E R      J R     C O N F E R E N C E    S E R I E S
4th Annual Bradley Z. Naifeh Amyloidosis Conference
Medical Professionals Day
Saturday, May 9, 2026 | Hybrid Symposium
TIMEPRESENTATIONSPEAKER(S)
7:00 AMRegistration & Breakfast
8:00 AMExecutive Welcome
Overview of Amyloidosis mission at Houston Methodist 		A. Osama Gaber, MD,FACS,FAST
8:05 AMIntroduction of the Bradley Z. Naifeh Amyloidosis Program Arvind Bhimaraj, MD, MPH, FACC, FHFSA
8:10 AMA message from the Naifeh Family Valerie Naifeh 
8:20 AMTypes of Amylodisois and the Numbers: Why We Care? Barry Trachtenberg, MD
PLENARY SESSION I: TTR Amyloidosis: A Fast Advancing Field
Moderators: Mahwash Kassi, MD; Arvind Bhimaraj, MD
Panelist: 
8:30 AMStage A to Stage D Cardiac Amyloidosis : A Paradigm to match the current landscapeArvind Bhimaraj, MD, MPH, FACC, FHFSA
9:00 AMUnderstanding Pathobiology of  TTR AmyloidosisLorena Saelices Gomez, Ph.D.
9:25 AMOrthopedics as a crucial speciality to beat ATTR at a population levelShari Liberman, MD
9:35 AMThe Neurotrophic  Manifestations of ATTR AmyloidosisSheetal Shroff, MBBS
9:45 AMQ&A and Panel Discussion
9:55 AMBreak 
PLENARY SESSION II: AL Amyloidosis: The Disease We Cannot Ignore
Moderators: Hematology, Mouz Al-Malah
Panelist: Mouz Al-Malah; Dipan Shah
10:10 AMAL Amyloidosis as a spectrum of plasma cell dyscarias or a uniquely seprate entityRaymond Comenzo, MD
10:40 AMImaging the Heart, Hope or Hype: Diagnostic ablity to distinguish subtypes and follow therapeutic reponseSarah Cuddy, MBBCh BAO, MD,FACC,FASNC
10:50 AMKidneys as the cornerstone of AL amyloidosis: Why nephrologists need to be Amyloid doctorsHoracio Adrogue, MD
11:00 AMQ&A and Panel Discussion
PLENARY SESSION III: Patient Perspective and Support Groups: How to Support our Patients
Moderators: Arvind Bhimaraj, MD; Barry Trachtenberg, MD
Panelist: 
11:10 AMPathways to Connect: Support Groups for Amyloidosis Patients
Amyoidosis Army, Amyloidosis Speakers Bureau,
Amyloidosis Research Consortium, Amyloidosis Support Groups,
Elevate Amyoidosis, Somebody To Talk To, Still4Life 		Arvind Bhimaraj, MD, MPH, FACC, FHFSA
Mahwash Kassi, MD
Barry Trachtenberg, MD
11:40 AMQ&A and Panel Discussion
11:50 PMLunch
11:50 PMPRODUCT THEATRE (Presented in Boardroom)
*Not certified for CE credit*
PLENARY SESSION IV: Treatment Options for Amyloidosis
Moderators: Arvind Bhimaraj, MD; Barry Trachtenberg, MD
Panelist:
1:20 PMATTR treatment options: Current and FutureMahwash Kassi, MD
1:45 PMAL Amyloidosis Updates in TreatmentCarrie Yuen, MD
2:00 PMDEBATE: KNOCK IT DOWN: TTR IS NOT A CRITICAL PROTEIN FOR HUMAN HOMEOSTASIS (PR0)Sarah Cuddy, MBBCh BAO, MD,FACC,FASNC
2:15 PMDEBATE: KNOCK IT DOWN: TTR IS NOT A CRITICAL PROTEIN FOR HUMAN HOMEOSTASIS (CON)Lorena Saelices Gomez, Ph.D.
2:30 PMREBUTTAL: 3 min each 
2:50 PMQ&A and Panel Discussion
3:00 PMConcluding Remarks 
3:10 PMAdjourn
Virtual
United States

Virtual

Available Credit

  • 3.25 Attendance
Please login or register to take this course.

STEPS TO REGISTER:

  • STEP 1 - Select the applicable fee and add to cart to complete the checkout process.
  • STEP 2 - Once registered, click the "Take Course" button to begin the activity.